EMISPHERE TECHNOLOGIES INC Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 6 rows in 2011. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2011-09-19: Reporting owner RACHESKY MARK H MD; Form 4; Security Non-Qualified Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2011-09-19: Reporting owner WEISER MICHAEL; Form 4; Security Non-Qualified Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2011-09-19: Reporting owner HARKEY JOHN D JR; Form 4; Security Non-Qualified Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2011-09-19: Reporting owner ROTHWELL TIMOTHY G; Form 4; Security Non-Qualified Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2011-09-19 | RACHESKY MARK H MD Director | 4 | Non-Qualified Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +40,000 40,000 owned after | $1.53 exercise price | 2011-09-21 | |
| 2011-09-19 | WEISER MICHAEL Director | 4 | Non-Qualified Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +40,000 40,000 owned after | $1.53 exercise price | 2011-09-21 | |
| 2011-09-19 | HARKEY JOHN D JR Director | 4 | Non-Qualified Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +40,000 40,000 owned after | $1.53 exercise price | 2011-09-21 | |
| 2011-09-19 | ROTHWELL TIMOTHY G Director | 4 | Non-Qualified Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +40,000 40,000 owned after | $1.53 exercise price | 2011-09-21 | |
| 2011-07-15 | Riley Gary Officer (VP Nonclinical Dev & App. Bio.) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 135,000 owned after | $0.92 exercise price | 2011-07-19 | |
| 2011-07-15 | Garone Michael Officer (Interim CEO, CFO, Secretary) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +30,000 145,000 owned after | $0.92 exercise price | 2011-07-19 |